The discrepancy may have been due to different lupus-prone mouse models used or different activation methods (anti-CD40 versus LPS), although another study has shown that LPS could increase IL-6 production from BMDC of B6.Sle1.Sle2.Sle3 mice [39]. This evidence concerns the gene IL6 and systemic lupus erythematosus.